Literature DB >> 21444021

Drugs causing muscle disease.

Adam Mor1, Robert L Wortmann, Hal J Mitnick, Michael H Pillinger.   

Abstract

Many drugs can cause myopathies, and such myopathies may range widely from asymptomatic elevations in the serum creatine phosphokinase levels to severe myalgias, cramps, exercise intolerance, muscle weakness, and even rhabdomyolysis. In this article, some of the commonly used drugs that may induce myopathies, as well as the clinical phenotypes, diagnosis, and management of these syndromes are reviewed. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21444021     DOI: 10.1016/j.rdc.2011.01.005

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  5 in total

Review 1.  Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches?

Authors:  F Sanchis-Gomar; H Pareja-Galeano; C Perez-Quilis; A Santos-Lozano; C Fiuza-Luces; N Garatachea; G Lippi; A Lucia
Journal:  Cell Stress Chaperones       Date:  2014-09-03       Impact factor: 3.667

2.  Voriconazole- induced severe hypokalemic rhabdomyolysis: A case report.

Authors:  Abdulsalam Alawfi; Abdullah Algarni; Jocelyn Donesa; Motasem Abuelreish
Journal:  Int J Pediatr Adolesc Med       Date:  2021-03-21

3.  Pain assessment in hospitalized older adults with dementia and delirium.

Authors:  Christina May Paulson; Todd Monroe; Lorraine C Mion
Journal:  J Gerontol Nurs       Date:  2014-05-02       Impact factor: 1.254

4.  Acute Colchicine-induced Neuromyopathy in a Patient Treated with Atorvastatin and Clarithromycin.

Authors:  José M Olmos-Martínez; Helena Molina; Cristina Salas; José M Olmos; José L Hernández
Journal:  Eur J Case Rep Intern Med       Date:  2019-03-18

5.  Rash and elevated creatine kinase in a deployed soldier.

Authors:  Thomas W Schmidt; Mark Garfinkle; Daniel F Battafarano
Journal:  Mil Med       Date:  2014-02       Impact factor: 1.437

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.